News
However, AbbVie has also built a substantial oncology franchise with products like Imbruvica and Venclexta. Some key oncology ...
Earlier this month, Merck and Daiichi Sankyo announced that ifinatamab deruxtecan was granted Breakthrough Therapy Designation by the U.S. FDA for treating adult patients with extensive-stage small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results